![Reimar Schlingensiepen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Reimar Schlingensiepen
Directeur Général chez
AudioCure Pharma GmbH
Profil
Reimar Schlingensiepen is the founder of Isarna Therapeutics GmbH, serving as Chief Operating Officer from 2009 to 2012.
Dr. Schlingensiepen is currently the Chief Executive Officer of AudioCure Pharma GmbH since 2017.
Formerly, Dr. Schlingensiepen was the Chief Executive Officer of JADO Technologies GmbH from 2010 to 2014.
Postes actifs de Reimar Schlingensiepen
| Sociétés | Poste | Début |
|---|---|---|
AudioCure Pharma GmbH
 AudioCure Pharma GmbH Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Directeur Général | 22/05/2017 |
Anciens postes connus de Reimar Schlingensiepen
| Sociétés | Poste | Fin |
|---|---|---|
JADO Technologies GmbH
 JADO Technologies GmbH Drugstore ChainsRetail Trade Develops novel small molecule drugs | Directeur Général | 17/04/2014 |
Isarna Therapeutics GmbH
 Isarna Therapeutics GmbH BiotechnologyHealth Technology Develops cytokine human transforming growth factor-beta (TGF-beta) inhibitors | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
8
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Isarna Therapeutics GmbH
Isarna Therapeutics GmbH BiotechnologyHealth Technology Develops cytokine human transforming growth factor-beta (TGF-beta) inhibitors | Health Technology |
JADO Technologies GmbH
JADO Technologies GmbH Drugstore ChainsRetail Trade Develops novel small molecule drugs | Retail Trade |
AudioCure Pharma GmbH
AudioCure Pharma GmbH Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
